Antonella Calogero
Antonella Calogero
full professor sapienza university
Verified email at
Cited by
Cited by
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGF β 1, PTEN, p53, and fibronectin
V Baron, ED Adamson, A Calogero, G Ragona, D Mercola
Cancer gene therapy 13 (2), 115-124, 2006
EGR-1, the reluctant suppression factor
C Liu, A Calogero, G Ragona, E Adamson, D Mercola
Critical Reviews™ in Oncogenesis 7 (1-2), 1996
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas
A Calogero, A Arcella, G De Gregorio, A Porcellini, D Mercola, C Liu, ...
Clinical Cancer Research 7 (9), 2788-2796, 2001
Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo
V Baron, G De Gregorio, A Krones-Herzig, T Virolle, A Calogero, R Urcis, ...
Oncogene 22 (27), 4194-4204, 2003
Human herpesvirus 6 infection in neoplastic and normal brain tissue
L Cuomo, P Trivedi, MR Cardillo, FM Gagliardi, A Vecchione, R Caruso, ...
Journal of medical virology 63 (1), 45-51, 2001
Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia
LP Ruco, A Procopio, V Maccallini, A Calogero, S Uccini, L Annino, ...
Blood 61 (6), 1132-1137, 1983
Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells
M Storto, U De Grazia, G Battaglia, MP Felli, M Maroder, A Gulino, ...
Journal of neuroimmunology 109 (2), 112-120, 2000
Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells
M D'Onofrio, A Arcella, V Bruno, RT Ngomba, G Battaglia, V Lombari, ...
Journal of neurochemistry 84 (6), 1288-1295, 2003
Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma
A Calogero, V Lombari, G De Gregorio, A Porcellini, S Ucci, A Arcella, ...
Cancer cell international 4 (1), 1-12, 2004
Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas
S Messina, L Frati, C Leonetti, C Zuchegna, E Di Zazzo, A Calogero, ...
Oncogene 30 (35), 3813-3820, 2011
The inhibition of KCa3. 1 channels activity reduces cell motility in glioblastoma derived cancer stem cells
P Ruggieri, G Mangino, B Fioretti, L Catacuzzeno, R Puca, D Ponti, ...
PLoS One 7 (10), e47825, 2012
Serum‐activated K and Cl currents underlay U87‐MG glioblastoma cell migration
L Catacuzzeno, F Aiello, B Fioretti, L Sforna, E Castigli, P Ruggieri, ...
Journal of cellular physiology 226 (7), 1926-1933, 2011
Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci
EL Goode, JL Stanford, MA Peters, M Janer, M Gibbs, S Kolb, ...
Clinical cancer research 7 (9), 2739-2749, 2001
Human herpesvirus 6 variant A, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism
L Cuomo, A Angeloni, C Zompetta, M Cirone, A Calogero, L Frati, ...
AIDS research and human retroviruses 11 (10), 1241-1245, 1995
EMT/MET at the crossroad of stemness, regeneration and oncogenesis: the ying-yang equilibrium recapitulated in cell spheroids
E Forte, I Chimenti, P Rosa, F Angelini, F Pagano, A Calogero, ...
Cancers 9 (8), 98, 2017
An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture
MV Catania, A Copani, A Calogero, GI Ragonese, DF Condorelli, ...
Neuroscience 91 (4), 1529-1538, 1999
M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells
M Ferretti, C Fabbiano, MD Bari, C Conte, E Castigli, M Sciaccaluga, ...
Journal of cellular and molecular medicine 17 (4), 552-566, 2013
Altered expression of alpha-dystroglycan subunit in human gliomas
A Calogero, E Pavoni, T Gramaglia, G D'Amati, G Ragona, A Brancaccio, ...
Cancer biology & therapy 5 (4), 441-448, 2006
Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines.
A Calogero, L Cuomo, M D'Onofrio, U De Grazia, P Spinsanti, D Mercola, ...
Oncogene 13 (10), 2105-2112, 1996
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report
C Capalbo, P Marchetti, A Coppa, A Calogero, E Anastasi, A Buffone, ...
Cancer biology & therapy 15 (7), 826-831, 2014
The system can't perform the operation now. Try again later.
Articles 1–20